News - See what's new!
Find all the latest information on upcoming events, product developments, and company announcements.
ENGAGING PATIENTS WITH THEIR AMD CARE
Clinicians are keenly aware of the need to keep patients onboard with treatment and never more so with a condition which shows no real benefit of treatment. Visualisation - black means fluid, and grey means abnormal blood vessels - is the key to ensuring that patients return regularly and engage with sight-saving therapies
Read morePATIENT MANAGEMENT WITH LIMITED RESOURCES
With an array of breakthrough drugs in the pipeline, clinicians are being urged to upskill and healthcare managers should prepare patient pathways. Mindful of costs, the price of treatment may be considerably less than residential care for a patient who is no longer able to look after themselves and requires round the clock nursing.
Read moreMAP AND TRACK AMD WITH MACHINE LEARNING AND AI
Causing three times the sight loss of any other ocular morbidity, AMD can be a devastating diagnosis. By using AI to identify the patients with the greatest opportunity for effective treatment, there is a cause for optimism as the enormous benefits of machine learning are put to work.
Read moreACTOR, PHILLIP VAN LEAR, SHARES HIS GLAUCOMA JOURNEY
To support World Glaucoma Week, on behalf of Heidelberg Engineering, Janice English interviewed Phillip Van Lear to raise awareness of the importance of early detection of glaucoma and treatment at the right time. Read about his personal journey and share it with your patients.
Read moreTHE TECHNOLOGICAL FIGHT AGAINST THE SILENT THIEF OF SIGHT
Advances in optical coherence tomography (OCT) technology, new treatments and innovative research are contributing to earlier detection of glaucoma. Uncover more about the importance of patient awareness, confident diagnosis and treatment at the right time in this captivating interview with Dr. Christian Mardin, Consultant Ophthalmologist at the Friedrich-Alexander University Erlangen-Nuremberg and Dr. Sanjay Asrani, Professor of Ophthalmology at Duke Eye Centre, North Carolina.
Read moreDr. Arturo Chayet: Transforming Ophthalmology practice with ANTERION® with swept-source OCT Technology
In this interview Dr. Arturo Chayet shares his experience on the implementation of ANTERION® with swept-source OCT technology in his medical practice.
Read more“AT RISK CORNEAS” ARE MORE EASILY IDENTIFIED WITH SCORE
Risk assessment of post-LASIK corneal ectasia in refractive surgery patients is now a more exact, objective, evaluation thanks to the work of Heidelberg Engineering and a leading research partner in Paris.
Read moreANTERION PLAYS SIGNIFICANT ROLE IN PREMIUM IOL SELECTION
Accessing additional data for premium IOL selection is essential for patient satisfaction, and this is where the recently FDA-approved Heidelberg Engineering’s ANTERION can play a valuable role.
Read moreHow ANTERION can support clinicians in complex cataract surgery planning
ANTERION® from Heidelberg Engineering is a comprehensive all-in-one-solution for optical biometry and IOL power predictions. ANTERION provides high-resolution images of the anterior segment by combining SS-OCT technology with eye tracking.
Read moreThe importance of multimodal imaging in the diagnosis of AMD and geographic atrophy
The U.S. Food and Drug Administration (FDA) has approved a drug for the treatment of geographic atrophy (GA) for the first time, one of the advanced forms of dry age-related macular degeneration (AMD). The approval is considered a breakthrough in ophthalmology and finally gives patients hope of positively impacting the course of the disease.
Read more